RAYMOND BAUTISTA
Sports Medicine Podiatrist in LONG BEACH, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: RAYMOND BAUTISTA reported a CMS MIPS final score of 0 out of 100, below the 83.1 national average, and filed 1,016 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
RAYMOND BAUTISTA at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Sports Medicine Podiatrist compares to other specialties among California providers
Sports Medicine Podiatrist share within California
Sports Medicine Podiatrist is one of the more visible NUCC categories in California
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
RAYMOND BAUTISTA's 2023 MIPS final score plotted against the Sports Medicine Podiatrist national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Sports Medicine Podiatrist) — 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Sports Medicine Podiatrist US NPIs
0/100 MIPS final score — 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Sports Medicine Podiatrist. Quality dim: 0.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
RAYMOND BAUTISTA is a Sports Medicine Podiatrist provider practicing in LONG BEACH, California, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1043265549. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
RAYMOND BAUTISTA appears in the CMS NPPES registry as a Sports Medicine Podiatrist provider at 701 E 28TH ST, LONG BEACH, CA, 90806, with a listed phone of (562) 426-2551. NPI 1043265549 was issued on 05/23/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BAUTISTA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,016 prescription claims written by this provider, covering 301 Medicare beneficiaries and totaling roughly $49K in drug spend, split 9% brand-name and 91% generic by claim count, with an opioid prescribing rate of 20.8%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Sports Medicine Podiatrist is a narrow specialty nationwide, with 134 enrolled providers across 30 states and an average of 253 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1043265549 |
|---|---|
| Specialty | Sports Medicine Podiatrist |
| Gender | Male |
| NPI Issued | 05/23/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm RAYMOND BAUTISTA's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where RAYMOND BAUTISTA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RAYMOND BAUTISTA. Source: openpaymentsdata.cms.gov.
Total received
$639
Largest payer
Stryker Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — California MBC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to RAYMOND BAUTISTA. To verify RAYMOND BAUTISTA's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 91% generic, on 1,016 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,120
- Total Day Supply
- 26,778
- Brand vs Generic
- 9% brand / 91% generic
- Brand Drug Cost
- $18K
- Generic Drug Cost
- $31K
- Opioid Claims
- 211 (20.8% rate)
- Antibiotic Claims
- 72
Patient Demographics
- Average Patient Age
- 72.2 years
- Avg HCC Risk Score
- 2.19
- Gender Split
- 49% female / 51% male
- Age Distribution
- <65: 40, 65-74: 146, 75-84: 82, 85+: 33
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Ciclopirox Ciclopirox Olamine | 172 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 143 |
| Diclofenac Sodium | 136 |
| Ketoconazole | 70 |
| Ssd Silver Sulfadiazine | 51 |
| Triamcinolone Acetonide | 50 |
| Tramadol Hcl | 30 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 28 |
| Doxycycline Hyclate | 28 |
| Ammonium Lactate | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Sports Medicine Podiatrist Overview
How RAYMOND BAUTISTA fits within the Sports Medicine Podiatrist landscape nationally.
RAYMOND BAUTISTA's 1,016 claims are above the specialty average of 253.
Nearby Sports Medicine Podiatrist Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as BAUTISTA.
Compare Sports Medicine Podiatrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore California
Frequently Asked Questions
What is RAYMOND BAUTISTA's specialty? ▼
How much does RAYMOND BAUTISTA prescribe under Medicare Part D? ▼
What is RAYMOND BAUTISTA's Medicare quality score? ▼
Where is RAYMOND BAUTISTA located? ▼
What is RAYMOND BAUTISTA's NPI number? ▼
Does RAYMOND BAUTISTA prescribe more brand-name or generic drugs? ▼
Does RAYMOND BAUTISTA prescribe opioids? ▼
How many Sports Medicine Podiatrist providers are there in the US? ▼
What drugs does RAYMOND BAUTISTA prescribe most often? ▼
Does RAYMOND BAUTISTA accept Medicare? ▼
How can I verify RAYMOND BAUTISTA's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology